Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPRT1 | P00492 | 6/20 | 0.42 |
| ▸ | PNP | P00491 | 2/20 | 0.42 |
| ▸ | ADCY5 | O95622 | 1/20 | 0.39 |
| ▸ | HINT1 | P49773 | 2/20 | 0.39 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.39 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6717369 | 1.00 | HPRT1 (0.42) | HPRT1PNPADCY5HINT1ADORA3 | |
| SCHEMBL6710531 | 0.84 | ADCY5 (0.38) | ADCY5 | |
| SCHEMBL6710540 | 0.84 | ADCY5 (0.43) | ADCY5ADORA3 | |
| SCHEMBL6711464 | 0.83 | ADCY5 (0.60) | ADCY5 | |
| SCHEMBL6711467 | 0.83 | ADCY5 (0.60) | ADCY5 | |
| SCHEMBL6710536 | 0.83 | PNP (0.31) | PNP | |
| SCHEMBL4850989 | 0.81 | PNP (0.49) | HPRT1PNPADCY5ADORA3 | |
| SCHEMBL6717390 | 0.78 | HPRT1 (0.34) | HPRT1 | |
| SCHEMBL6711555 | 0.77 | KMT2A (0.35) | — | |
| SCHEMBL6711549 | 0.77 | KMT2A (0.35) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040249152-A1 | Method for the production of cna | NANOGEN RECOGNOMICS GMBH (DE) | 2004-12-09 | — | — | US | claimed |
| US-20040249152-A1 | Method for the production of cna | NANOGEN RECOGNOMICS GMBH (DE) | 2004-12-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040249152-A1 | Method for the production of cna | RNGTT, COASY, CNOT7 | HPRT1 2683/4885PNP 378/4885ADCY5 1851/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.